期刊
BIOMEDICINE & PHARMACOTHERAPY
卷 137, 期 -, 页码 -出版社
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.biopha.2021.111401
关键词
Exosome; Radiotherapy; Radiation damage; Biomarker; Tumor; Therapy
资金
- National Natural Science Foundation of China [81773353]
- Jilin Scientific and Technological Development Program [20190201204JC, 20200601005JC]
- Jilin Province special project of Medical and health talents [JLSCZD2019031]
Radiotherapy is a significant treatment for tumors, but it can cause radiation damage to normal tissues. Exosomes, nanoscale vesicles containing complex miRNAs and proteins, have shown potential as biomarkers for diseases and in treatment of radiation damage by regulating inflammatory response and promoting tissue repair.
Radiotherapy is one of the three main treatments for tumors. Almost 70% of tumor patients undergo radiotherapy at different periods. Although radiotherapy can enhance the local control rate of tumors and patients? quality of life, normal tissues often show radiation damage following radiotherapy. In recent years, several studies have shown that exosomes could be biomarkers for diseases and be involved in the treatment of radiation damage. Exosomes are nanoscale vesicles containing complex miRNAs and proteins. They can regulate the inflammatory response, enhance the regeneration effect of damaged tissue, and promote the repair of damaged tissues and cells, extending their survival time. In addition, their functions are achieved by paracrine signaling. In this review, we discuss the potential of exosomes as biomarkers and introduce the impact of exosomes on radiation damage in different organs and the hematopoietic system in detail.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据